LINC00623 was shown to promote the tumorigenicity and migratory capacity of #pancreatic ductal adenocarcinoma (PDAC) cells in vitro and in vivo, showing that it is a potential biomarker and therapeutic target 🎯 for PDAC. ⬇️⬇️⬇️ https://t.co/xOOB0JEUIY htt
The LINC00623/NAT10 signaling axis promotes pancreatic cancer progression by remodeling ac4C modification of mRNA https://t.co/mMi5HneZ4Z https://t.co/cjyXfoxDBg
New article: The LINC00623/NAT10 signaling axis promotes pancreatic cancer progression by remodeling ac4C modification of mRNA https://t.co/13ddSgEwIL #pancreaticcancer #oncology https://t.co/uEaku3L5gJ